文献速递前列腺癌前列腺增生与排尿功能障碍

比较前列腺切除术后由FPMRS指导的当面盆底治疗项目与无监督盆底锻炼的疗效

Comparison of In-person FPMRS-directed Pelvic Floor Therapy Program Versus Unsupervised Pelvic Floor Exercises Following Prostatectomy.
PubMed 文献 · Urology · 2023-06-21

该回顾性研究比较前列腺切除术后接受FPMRS专科医师监督的12个月盆底肌训练(PFMT)与标准无监督家庭盆底锻炼(UPFE)的失禁结局,共纳入40例男性。PFMT组在6个月和12个月时的SUI症状评分均显著优于UPFE组,但12个月时SUI治愈概率、每日护垫使用量及生活质量评分两组无显著差异。

要点

  • PFMT组6个月SUI症状评分0.81±0.21 vs UPFE组1.75±0.34(P=0.014),12个月0.72±0.17 vs 1.67±0.30(P=0.004)
  • 12个月随访时PFMT组11例(55%)报告无SUI vs UPFE组4例(20%)
  • 12个月SUI治愈预测概率PFMT组0.52±0.14 vs UPFE组0.23±0.13(P=0.14),未达统计学显著

核心结论

  • 当面、由FPMRS指导的PFMT与机器人辅助腹腔镜前列腺切除术后SUI症状评分改善相关,该效果持续至12个月随访。

研究设计与样本

  • 回顾性分析前瞻性收集的纵向结局数据,比较接受12个月PFMT项目(FPMRS专科医师监督)与UPFE的患者,随访至12个月。
  • 共纳入40例男性患者。
  • 主要结局为ICIQ-MLUTS SUI域评分(SDS),次要结局包括每日护垫使用量(PPD)、SUI治愈(SDS=0)及生活质量评分(IIQ-7)。
  • 采用多水平混合效应线性回归对SDS随时间变化建模。

主要发现

  • PFMT组与UPFE组患者特征比较均无差异(P=NS)。
  • 6个月时平均预测SDS PFMT组0.81±0.21 vs UPFE组1.75±0.34(P=0.014);12个月时PFMT组0.72±0.17 vs UPFE组1.67±0.30(P=0.004)。
  • 12个月随访时报告无SUI者PFMT组11例(55%) vs UPFE组4例(20%)。
  • 12个月SUI治愈预测概率PFMT组0.52±0.14 vs UPFE组0.23±0.13(P=0.14)。
  • 12个月随访时平均预测PPD PFMT组0.19±0.10 vs UPFE组0.79±0.33,IIQ评分PFMT组2.86±0.86 vs UPFE组2.55±1.07,均P=NS。

关键数值与推荐

  • PFMT组6个月平均预测SDS为0.81±0.21,UPFE组为1.75±0.34(P=0.014)。
  • PFMT组12个月平均预测SDS为0.72±0.17,UPFE组为1.67±0.30(P=0.004)。
  • 12个月SUI治愈预测概率PFMT组0.52±0.14 vs UPFE组0.23±0.13(P=0.14)。
  • 12个月平均预测PPD PFMT组0.19±0.10 vs UPFE组0.79±0.33(P=NS)。
  • 12个月平均预测IIQ评分PFMT组2.86±0.86 vs UPFE组2.55±1.07(P=NS)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare comprehensive continence outcomes in patients receiving pelvic floor muscle training (PFMT) vs standard unsupervised home pelvic floor exercise therapy (UPFE). METHODS: As part of the UVA prostatectomy functional outcomes program, participating patients complete a 12-month PFMT program under FPMRS specialist supervision. We performed a retrospective review of prospectively collected longitudinal outcomes in patients receiving PFMT vs UPFE through 12-month follow-up. Primary study outcome was ICIQ-MLUTS SUI domain score (SDS). Secondary outcomes included daily pad use (PPD), SUI Cure (SDS=0), and quality of life score (IIQ-7). Multilevel mixed effects linear regression was used to model SDS over time. RESULTS: Analysis included 40 men. No difference in patient characteristics was seen in comparison of PFMT vs UPFE cohorts (P = NS, all comparisons). Mean predicted SDS was significantly better in the PFMT vs UPFE cohorts at 6-month (0.81 ± 0.21 vs 1.75 ± 0.34, respectively) (P = .014) and 12-month (0.72 ± 0.17 vs 1.67 ± 0.30, respectively) (P = .004) time points. At 12-month follow-up, 11 (55%) vs 4 (20%) patients reported absence of SUI in PFMT vs UPFE cohorts, respectively. Predicted probabilities of SUI cure in PFMT vs UPFE cohorts at 12months were 0.52 ± 0.14 vs 0.23 ± 0.13, respectively (P = .14). At 12-month follow-up, the mean predicted PPD and IIQ score was 0.19 ± 0.10 vs 0.79 ± 0.33 and 2.86 ± 0.86 vs 2.55 ± 1.07 in PFMT vs UPFE cohorts, respectively (P = NS). CONCLUSION: In-person, FMPRS-directed PFMT is associated with improved SUI domain scores following robotic-assisted laparoscopic prostatectomy, a finding durable through 12-month follow-up.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Rapp DE, Farhi J, DeNovio A, et al. Comparison of In-person FPMRS-directed Pelvic Floor Therapy Program Versus Unsupervised Pelvic Floor Exercises Following Prostatectomy. Urology. 2023. PMID: 37353089. doi:10.1016/j.urology.2023.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。